2012-10-09 00:22:43 - New Pharmaceuticals market report from Global Markets Direct: "Samyang Holdings Corporation - Product Pipeline Review - 2012"

Global Market Direct's pharmaceuticals report, "Samyang Holdings Corporation - Product Pipeline Review - 2012" provides data on the Samyang Holdings Corporation's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Samyang Holdings Corporation's corporate website, SEC filings, investor presentations and featured press releases, both from Samyang Holdings Corporation and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

* Samyang Holdings Corporation - Brief Samyang Holdings Corporation overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current

pipeline of Samyang Holdings Corporation human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Samyang Holdings Corporation with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Samyang Holdings Corporation's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.


Full Report Details at
- www.fastmr.com/prod/468601_samyang_holdings_corporation_product_ ..


Reasons to buy

* Evaluate Samyang Holdings Corporation's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Samyang Holdings Corporation in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Samyang Holdings Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Samyang Holdings Corporation.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Samyang Holdings Corporation and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Samyang Holdings Corporation Snapshot
Samyang Holdings Corporation Overview
Key Information
Key Facts
Samyang Holdings Corporation - Research and Development Overview
Key Therapeutic Areas
Samyang Holdings Corporation - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Samyang Holdings Corporation - Pipeline Products Glance
Samyang Holdings Corporation Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Samyang Holdings Corporation - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Samyang Holdings Corporation - Drug Profiles
docetaxel
Product Description
Mechanism of Action
R&D Progress
Drug For Hyperlipidemia
Product Description
Mechanism of Action
R&D Progress
Drug For Hypertension
Product Description
Mechanism of Action
R&D Progress
Genexol-PM + Carboplatin
Product Description
Mechanism of Action
R&D Progress
Immunosupressant Drug
Product Description
Mechanism of Action
R&D Progress
itraconazole
Product Description
Mechanism of Action
R&D Progress
Paclitaxel
Product Description
Mechanism of Action
R&D Progress
paclitaxel-loaded polymeric micelle
Product Description
Mechanism of Action
R&D Progress
Samyang Holdings Corporation - Pipeline Analysis
Samyang Holdings Corporation - Pipeline Products by Therapeutic Class
Samyang Holdings Corporation - Pipeline Products by Route of Administration
Samyang Holdings Corporation - Pipeline Products By Mechanism of Action
Samyang Holdings Corporation - Dormant Projects
Samyang Holdings Corporation - Company Statement
Samyang Holdings Corporation - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Financial Deals Landscape
Samyang Holdings Corporation, Deals Summary
Samyang Holdings Corporation, Pharmaceuticals & Healthcare, Deal Details
Partnerships
Takeda Pharma Enters Into Research Collaboration With Samyang
Daewon Pharma Enters Into Strategic Alliance With Samyang Corporation
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Samyang Holdings Corporation, Key Information
Samyang Holdings Corporation, Key Facts
Samyang Holdings Corporation - Pipeline by Indication, 2012
Samyang Holdings Corporation - Pipeline by Stage of Development, 2012
Samyang Holdings Corporation - Monotherapy Products in Pipeline, 2012
Samyang Holdings Corporation - Combination Treatment Modalities in Pipeline, 2012
Samyang Holdings Corporation - Phase II, 2012
Samyang Holdings Corporation - Phase I, 2012
Samyang Holdings Corporation - Pre-Clinical, 2012
Samyang Holdings Corporation - Pipeline By Therapeutic Class, 2012
Samyang Holdings Corporation - Pipeline By Route of Administration, 2012
Samyang Holdings Corporation - Pipeline Products By Mechanism of Action, 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468601&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.